Milestone Scientific Inc. Announces Increase in Authorized Common Shares

Key Highlights

• Amendment to Certificate of Incorporation Approved and Filed:
  Milestone Scientific Inc. (“the Company”) has amended its Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 125,000,000.
• Stockholder Approval:
  The amendment was approved by shareholders at the Company’s annual meeting held on December 18, 2025.
• Effective Date:
  The Certificate of Amendment was filed with the Secretary of State of the State of Delaware on March 10, 2026, and became effective upon filing.
• Exchange Information:
  Milestone Scientific Inc.’s common stock trades on the NYSE American under the symbol MLSS.
• Other Corporate Details:
  The Company is incorporated in Delaware and its principal executive offices are located at 425 Eagle Rock Road, Ste 403, Roseland, New Jersey, 07068. The CEO is Eric Hines.

Details Investors Should Know

The increase in authorized shares potentially provides Milestone Scientific Inc. with greater flexibility for future capital raising activities, stock-based acquisitions, equity compensation plans, or other corporate purposes. While this amendment itself does not immediately dilute existing shareholders, it does enable the Company to issue up to 25 million additional shares in the future without further stockholder approval, except as may be required by applicable laws or stock exchange rules.

Shareholder Impact and Price Sensitivity:

• The approval and filing of this amendment is a significant corporate action, as it may impact the supply of shares available in the market. The potential for future equity offerings or issuance of new shares may be viewed as dilutive and could exert downward pressure on the stock price if new shares are issued at a price below current market value.
• Conversely, the increased capacity may also be seen as a positive, giving the Company room to pursue growth opportunities, acquisitions, or strengthen its balance sheet if needed.

All other provisions of the Company’s Restated Certificate of Incorporation remain unchanged.

Exhibits and Filing Details

• A copy of the Certificate of Amendment of Restated Certificate of Incorporation is attached as Exhibit 3.1 to the Form 8-K filing. The Company intends to file the complete Certificate of Incorporation, as amended, with its next Securities Act registration statement or periodic report in accordance with SEC requirements.
• The Form 8-K was signed by Eric Hines, Chief Executive Officer, on March 10, 2026.

Potential Share Price Impact

This increase in authorized shares is a potentially price-sensitive event for Milestone Scientific Inc. shareholders. Investors should monitor the Company’s announcements for any new equity offerings, stock splits, merger activity, or other corporate actions that might utilize the newly authorized shares.

Disclaimer

This article is for informational purposes only and does not constitute financial or investment advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions related to Milestone Scientific Inc. or its securities.

View MILESTONE SCIENTIFIC INC. Historical chart here